Brand Name
Carteolol
View Brand InformationFDA approval date: January 05, 2000
Classification: beta-Adrenergic Blocker
Form: Solution
What is Carteolol?
Carteolol Hydrochloride Ophthalmic Solution 1% has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma and intraocular hypertension. It may be used alone or in combination with other intraocular pressure lowering medications.
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment